tiprankstipranks
Advertisement
Advertisement

AU:CHM Stock Latest News

Chimeric posts positive early CHM CDH17 CAR-T data in metastatic GI cancers
Company AnnouncementsChimeric posts positive early CHM CDH17 CAR-T data in metastatic GI cancers
3h ago
CHM
Chimeric Therapeutics Seeks ASX Quotation for Additional Shares
PremiumCompany Announcements
Chimeric Therapeutics Seeks ASX Quotation for Additional Shares
20d ago
CHM
Chimeric Therapeutics Seeks ASX Quotation for New Share Issue
PremiumCompany Announcements
Chimeric Therapeutics Seeks ASX Quotation for New Share Issue
20d ago
CHM
Chimeric Therapeutics Plans Modest Share Placement on ASX
PremiumCompany Announcements
Chimeric Therapeutics Plans Modest Share Placement on ASX
24d ago
CHM
Chimeric Therapeutics Updates Capital Structure After Option Expiry
PremiumCompany Announcements
Chimeric Therapeutics Updates Capital Structure After Option Expiry
27d ago
CHM
Chimeric Therapeutics Issues 10 Million Long-Dated Unquoted Options
PremiumCompany AnnouncementsChimeric Therapeutics Issues 10 Million Long-Dated Unquoted Options
28d ago
CHM
Chimeric Therapeutics Issues New Shares Under Corporations Act Disclosure Exemption
Premium
Company Announcements
Chimeric Therapeutics Issues New Shares Under Corporations Act Disclosure Exemption
28d ago
CHM
Chimeric Therapeutics Seeks ASX Quotation for 6.9 Million New Shares
Premium
Company Announcements
Chimeric Therapeutics Seeks ASX Quotation for 6.9 Million New Shares
28d ago
CHM
Chimeric Therapeutics to List 733,333 New Shares on ASX
PremiumCompany Announcements
Chimeric Therapeutics to List 733,333 New Shares on ASX
1M ago
CHM
Chimeric Therapeutics Issues Unquoted Convertible Note Warrants
PremiumCompany Announcements
Chimeric Therapeutics Issues Unquoted Convertible Note Warrants
1M ago
CHM
Chimeric Therapeutics Issues New Unquoted Options and Convertible Notes
PremiumCompany Announcements
Chimeric Therapeutics Issues New Unquoted Options and Convertible Notes
1M ago
CHM
Chimeric Therapeutics Advances Lead CAR T Program and Reports Strong CORE-NK Trial Data
PremiumCompany Announcements
Chimeric Therapeutics Advances Lead CAR T Program and Reports Strong CORE-NK Trial Data
1M ago
CHM
Chimeric Therapeutics Finalises ASX Security Consolidation
PremiumCompany AnnouncementsChimeric Therapeutics Finalises ASX Security Consolidation
1M ago
CHM
Chimeric Therapeutics Secures Shareholder Approval for Capital Consolidation
Premium
Company Announcements
Chimeric Therapeutics Secures Shareholder Approval for Capital Consolidation
1M ago
CHM
Chimeric Therapeutics Wins Shareholder Backing for Capital Restructuring at EGM
Premium
Company Announcements
Chimeric Therapeutics Wins Shareholder Backing for Capital Restructuring at EGM
1M ago
CHM
Chimeric Therapeutics Flags Risks Around Forward-Looking Cell Therapy Statements
PremiumCompany Announcements
Chimeric Therapeutics Flags Risks Around Forward-Looking Cell Therapy Statements
2M ago
CHM
Chimeric Therapeutics to Showcase Cancer Cell Therapy Pipeline at NWR Virtual Healthcare Conference
PremiumCompany Announcements
Chimeric Therapeutics to Showcase Cancer Cell Therapy Pipeline at NWR Virtual Healthcare Conference
2M ago
CHM
Chimeric Therapeutics Launches Complex Capital Raising via Prospectus
PremiumCompany Announcements
Chimeric Therapeutics Launches Complex Capital Raising via Prospectus
2M ago
CHM
Chimeric Therapeutics Restructures Warrant Issue With Unchanged Total Value
PremiumCompany Announcements
Chimeric Therapeutics Restructures Warrant Issue With Unchanged Total Value
2M ago
CHM
Chimeric Therapeutics to Consolidate Shares and Equity Securities
PremiumCompany AnnouncementsChimeric Therapeutics to Consolidate Shares and Equity Securities
2M ago
CHM
Chimeric Therapeutics Sets Hybrid Extraordinary General Meeting for April 2026
Premium
Company Announcements
Chimeric Therapeutics Sets Hybrid Extraordinary General Meeting for April 2026
2M ago
CHM
Chimeric’s New Chair Refocuses Strategy Around Lead GI Cancer Cell Therapy
Premium
Company Announcements
Chimeric’s New Chair Refocuses Strategy Around Lead GI Cancer Cell Therapy
3M ago
CHM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >